 Immunotherapy generation eosinophil neutrophil chemotactic activity pollen season group birch pollen-allergic patients history rhinoconjunctivitis pollen season immunotherapy IT birch-pollen extract Pharmacia Uppsala Sweden Blood samples determination levels heat-labile eosinophil chemotactic activity HL-ECA heat-labile neutrophil chemotactic activity HL-NCA heat-stable neutrophil chemotactic activity season beginning study start season peak end birch-pollen season symptoms rhinoconjunctivitis airways peak expiratory flow use medication season Significant increases HL-ECA HL-NCA untreated IT-treated patients start season activities peak birch-pollen season end season HL-ECA levels different patient groups HL-NCA levels untreated patients IT generation HL-ECA HL-NCA pollen season